Structure-based analysis reveals a hydrophobic pocket governing P2Y₁₂ receptor agonist potency and selectivity.

Authors

Matteo Pavan, Jihyun Lee, John C Hancock, Paola Oliva, Masaki Terabe, Jinmyoung Joo, Kenneth A Jacobson

Published in

Journal of enzyme inhibition and medicinal chemistry. Volume 41. Issue 1. Pages 2726538. Epub Sep 25, 2026.

Abstract

Agonist of the ADP-activated P2Y₁₂ receptor modulate platelet aggregation and microglial function, yet the structural basis of their potency and selectivity remains unclear. Using recent active-state cryo-EM structures of P2Y₁₂ and P2Y₁ receptors, we applied an integrated modelling approach to revisit a structurally uncharacterised agonist series. We identify a previously unrecognised secondary hydrophobic pocket (SHP) adjacent to the orthosteric site as a key determinant of sub-nanomolar potency and receptor selectivity. Hydrophobic C2-alkylthio substituents engage this pocket and enhance potency by >2,000-fold, compensating for β-phosphate removal and otherwise intolerant N⁶ modifications. Differential SHP exposure explains P2Y₁₂/P2Y₁ selectivity, while non-conserved residues at positions 4.53 and 4.56 in SHP of P2Y₁₃R create a steric bottleneck to exclude bulky C2 substituents, enabling subtype discrimination. We further propose a revised P2Y₁R agonist-binding mode consistent with SAR and independently validated by cryo-EM. These findings establish a structure-based SAR framework and design principles for selective P2Y₁₂ agonists.

PMID:
42786908
Bibliographic data and abstract were imported from PubMed on 25 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.